冲击指数的实用性用于预测无补偿性心力衰竭中的死亡风险
Amanda Naidoo-Pillay1,2,3, Suma Rajan1,4, Andreas Engelbrecht1,2
1Division of Emergency Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Journal of the colleges of medicine of South Africa
|September 15, 2025
概括
反冲击指数 (RSI) 有效地预测了无补偿性心力衰竭 (HF) 的死亡率和关键干预措施. 在识别需要紧急护理的高风险HF患者方面,RSI优于冲击指数 (SI) 和改性冲击指数 (MSI).
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 临床预测工具 临床预测工具
背景情况:
- 不补偿性心力衰竭 (HF) 是一种严重的疾病,需要及时评估和管理.
- 冲击指数 (SI) 是一个验证的床边工具,用于预测HF患者的死亡率和发病率.
研究的目的:
- 评估SI,修改冲击指数 (MSI) 和逆冲击指数 (RSI) 在预测无补偿高频率患者的死亡率和关键干预措施中的有效性.
- 为了确定SI>0.9能否预测住院死亡率.
- 评估SI,MSI和RSI的72小时死亡率的预测值,需要通风,内热/血管压力器支持和内管道输管.
主要方法:
- 一个多中心的回顾性描述性研究,分析了六个月的急诊室记录.
- 评估SI,MSI和RSI作为死亡率和不补偿性HF的关键干预措施的预测指标.
- 统计分析以确定各种结果的几率比率 (OR) 和置信区间 (CI).
主要成果:
- 整体住院死亡率为4.3%.
- 12小时SI>0.9显著预测了对内的需要 (OR 12.33,CI 2.03-74.89,P=0.006).
- 在0小时RSI<1.0显示出对住院死亡率 (OR 8.89,CI 1.11-70.98) 和内使用 (OR 9.88,CI 1.70-57.27) 的显著预测值. MSI显示出潜在的潜力,但缺乏统计学意义.
结论:
- 在12小时内RSI>0.9是一个强有力的预测器,在去补偿的HF中增加了因诺托普的需求.
- RSI显示出对死亡率和关键干预措施的显著预测价值,表现优于SI和MSI.
- 建议进行进一步的前性研究,以验证这些发现,并指导临床实践早期风险分层.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.6K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.7K
相关概念视频
01:29Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
01:30Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
01:27Heart Failure I: Introduction
710
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710
01:30Heart Failure IV: Classification and Diagnostic Evaluation
323
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:22Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261